Skip to main content
OpenTrials
Completed

NCT Number: NCT06388915

A Retrospective Cohort Study of 15 Cases of Pelvic Fractures Complicated by Morel-Lavallee Lesion

Some related factors of pelvic fracture and Morel-Lavallee injury (MLL) are preliminarily discussed, which provides some preliminary references for early clinical detection and research of such injuries.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pelvic Fracture Femoral Fractures Fractures, Bone Hip Fractures Hip Injuries Leg Injuries Morel-Lavallee Lesion Wounds and Injuries

Sex eligibility

All sexes

Study type

Observational

Primary location

Fujian Provincial Hospital

Fuzhou, Fujian, 350000, China

About this study

Inclusion criteria

(1) The clinical symptoms are consistent with the diagnosis of pelvic fracture, and the diagnosis is confirmed by imaging, including emergency or sub-emergency CT data within 72 hours after injury. (2) The symptoms of the diagnosis of MLL were pain and swelling at the site of occurrence, a sense of soft tissue fluctuation found on physical examination, and a complete process of puncture drainage + negative pressure suction therapy. (3) The patients and their families have given informed consent to this study and signed the informed consent form, which meets the ethical requirements.

Exclusion criteria

(1) Incomplete imaging data, especially the lack of emergency or sub-emergency CT data within 72 hours after injury. (2) Cases of other severe lower limb fractures such as femur and trochanter, and lower limb fractures combined with MLL injury have been reported in the literature.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • (1) The clinical symptoms are consistent with the diagnosis of pelvic fracture, and the diagnosis is confirmed by imaging, including emergency or sub-emergency CT data within 72 hours after injury. (2) The symptoms of the diagnosis of MLL were pain and swelling at the site of occurrence, a sense of soft tissue fluctuation found on physical examination, and a complete process of puncture drainage + negative pressure suction therapy. (3) The patients and their families have given informed consent to this study and signed the informed consent form, which meets the ethical requirements.

Exclusion criteria

  • (1) Incomplete imaging data, especially the lack of emergency or sub-emergency CT data within 72 hours after injury. (2) Cases of other severe lower limb fractures such as femur and trochanter, and lower limb fractures combined with MLL injury have been reported in the literature.

Treatment and study plan

Primary outcomes

  1. Site of MLL

    Time frame: 5 days

    Site of the occurrence of Morel-Lavallee lesion

  2. Site of injury and Classification of pelvic fracture

    Time frame: 72 hours

    Site of injury and Classification of pelvic fracture

Secondary outcomes

  1. Time to treatment

    Time frame: 10 days

    Time of treatment for Morel-Lavallee lesion

  2. Drainage volume

    Time frame: 10 days

    Drainage volume for Morel-Lavallee lesion

Sponsors and collaborators

Lead sponsor

Weikang Chen

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Apr 29, 2024
Registry last updated
Apr 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.